4,4,4-Trifluoro-1-(4-trifluoromethylphenyl)-1,3-butanedione, 1g

2-(4,4-Difluoropiperidin-1-yl)-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine, 98%, 5mg

5,6,7,8-tetrahydro-4H-furo[3,2-c]azepin-4-one, 95.0%, 250mg

4-Chloro-2-(trifluoromethyl)benzoic acid, 95.0%, 10g

3-amino-1H-1,2,4-triazole-5-carboxylic acid, 95.0%, 25g

Buffer solution pH 10.00 ±0.01 (20 °C), ROTI®Star, 500 ml, plastic packaging.

6-(Trifluoromethoxy)pyridin-2-amine, 95.0%, 1g

3-Bromo-4-fluorotoluene, 99.0%, 500g

1-Bromo-2-ethylbenzene>98.0%(GC)25g

Ethyl 4-hydroxy-6-(trifluoromethyl)nicotinate, 95.0%, 250mg

tert-Butyl 7-(aminomethyl)-5-oxa-2-azaspiro[3.4]octane-2-carboxylate, 97%, 500mg

(2E)-3-(2,4-dichlorophenyl)-1-(2,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

Methyl 2,4-dimethylbenzoate, 95.0%, 1g